Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human sodium/iodide symporter-mediated radioiodine gene therapy enhances the killing activities of CTLs in a mouse tumor model.

Molecular cancer therapeutics - 1 Jan 2010

Jeon Yong Hyun, Choi Yun, Kim Chul Woo, Kim Young-Hwa, Youn Hyewon, Lee Jaetae, Chung June-Key

Abstract excerpt

We examined whether human sodium/iodide symporter (hNIS) radioiodine gene therapy can modulate the phenotype of cancer cells and enhance the killing activities of CTLs in a mouse tumor model. Various doses of I-131 (75, 300, 600, 1,200, and 2,400 microCi/5 mL) were incubated with hNIS-expressing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-2 Antigen
Share to CD11c Antigen
Share to Cytotoxicity, Immunologic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Iodine Radioisotopes

Share to Lymphocyte Count

Share to Lymphocytes, Tumor-Infiltrating

Share to Symporters

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 20053774
DOI: 10.1158/1535-7163.MCT-09-0540

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20053774-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Human sodium/iodide symporter-mediated radioiodine gene therapy enhances the killing activities of CTLs in a mouse tumor model.PMID 20053774Read ↗

The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131.Semantic proximity Read ↗

A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene DeliverySemantic proximity Read ↗

The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatmentSemantic proximity Read ↗

Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma.Semantic proximity Read ↗

Noninvasive Imaging of the Transcriptional Activities of Human Telomerase Promoter Fragments in MiceSemantic proximity Read ↗

In vivo imaging and tumor therapy with the sodium iodide symporterSemantic proximity Read ↗

Sodium Iodide Symporter for Nuclear Molecular Imaging and Gene Therapy: From Bedside to Bench and BackSemantic proximity Read ↗

Novel therapy for gastric cancer peritoneal dissemination using genetically modified dental pulp cells and astatine-211Semantic proximity Read ↗

A novel EGFP-expressing nude mice with complete loss of lymphocytes and NK cells to study tumor-host interactions.Semantic proximity Read ↗

The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene DeliverySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.